Revenue: The sum of all revenue fields included for a company's operating activities.
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-7.32M |
|
-- |
|
-- |
|
$11.76M |
|
$-11.76M |
|
$4.11M |
|
$-7.64M |
|
$-7.64M |
|
$-7.32M |
|
$-7.32M |
|
$-7.32M |
|
$-7.32M |
|
$-11.76M |
|
$-11.43M |
|
0.05M |
|
0.05M |
|
$-127.79 |
|
$-127.79 |
|
| Balance Sheet Financials | |
$11.26M |
|
$0.41M |
|
$7.63M |
|
$18.89M |
|
$6.43M |
|
$0.15M |
|
$1.82M |
|
$8.25M |
|
$10.63M |
|
$3.42M |
|
$10.63M |
|
0.07M |
|
| Cash Flow Statement Financials | |
$-15.67M |
|
$-0.76M |
|
$10.94M |
|
$7.63M |
|
$2.13M |
|
$-5.50M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.75 |
|
-- |
|
-- |
|
0.01 |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.84% |
|
-214.09% |
|
-38.76% |
|
-67.88% |
|
$159.06 |
|
$-316.59 |
|
$-316.35 |
|